Inhibition of CD47 signaling by monoclonal antibodies (mAb) helps macrophages to eliminate cancer cells and reduces tumor growth, leading to a potential curative approach when tumors are treated in their initiation phase [88]. This evidence concerns the gene CD47 and cancer.